Mr Richard Alcock (Western Sydney Local Health District), Ms Elizabeth Koff (Telstra Health), Ms Susan Pearce (NSW Health), Prof. Mark Scott (University of Sydney), Dr. Teresa Anderson (Sydney Local Health District) and Prof. Robyn Ward (University of Sydney) at the announcement event.
Scientists at the Accelerator will conduct cutting edge research into the building blocks of life, regenerative medicine, drug discovery and medical device development and harness the latest in nanotechnology and gene and stem cell therapy to transform health outcomes in the state.
Vice-Chancellor and President, Professor Mark Scott AO, said the investment is a key component of the University’s new 10-year strategy.
“This is a historic investment for any University. The range of world-class buildings and facilities that will make up the Sydney Biomedical Accelerator will bring together the brightest scientific and clinical minds with entrepreneurs, industry and government,” Professor Scott said.
“It gives our renowned researchers and partners the infrastructure to take a major step forward in the global quest to find solutions to our biggest health challenges. Together, we have the potential to dramatically improve the future of health and medical care in this country.
“Once the Accelerator is completed, the long-term relationship between our University and the Royal Prince Alfred Hospital will be further strengthened by the physical sharing and linkage of facilities, accelerating the pathway between findings made at a patient’s bedside to the research bench and back again.”
